Intellectual Property India Publishes Patent Application for 'Radiopharmaceutical Compositions Targeting Ephrin Type-A Receptor 2 And Uses Thereof' Filed by Rayzebio, Inc.

MUMBAI, India, May 16 -- Intellectual Property India has published a patent application (202517040913 A) filed by Rayzebio, Inc., San Diego, on April 28, for 'radiopharmaceutical compositions targeting ephrin type-a receptor 2 and uses thereof.'

Inventor(s) include Amso, Zaid; He, Rongjun; Cole, Derek; Noncovich, Alain; Ehara, Takeru; Ohuchi, Masaki; Nagasawa, Takayuki; Nakano, Shunichi; Morimoto, Kouki; Jitsuoka, Makoto; Enya, Sora; Aoki, Takanori; and Yanagida, Hayato.

The application for the patent was published on May 16, under issue no. 20/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are radiopharmaceutical conjugate compositions targeting EphA2 and uses thereof. In one aspect, provid...